TF Capital
47
40M
39
4.27
2
0.15
4
- Stages of investment
- Areas of investment
Summary
The venture was found in Asia in China. The main office of represented VC is situated in the Pudong.
The fund has exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight ZAI Lab, Antengene Corporation, Asieris Pharmaceuticals. Among the most successful fund investment fields, there are Biopharma, Pharmaceutical. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.
The fund is constantly included in 2-6 investment rounds annually. The increased amount of exits for fund were in 2017. Deals in the range of 10 - 50 millions dollars are the general things for fund. This TF Capital works on 22 percentage points less the average amount of lead investments comparing to the other organizations. Considering the real fund results, this VC is 13 percentage points less often commits exit comparing to other organizations. The top activity for fund was in 2018. Despite it in 2019 the fund had an activity.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the TF Capital, startups are often financed by Qiming Venture Partners, Sequoia Capital China, Kleiner Perkins. The meaningful sponsors for the fund in investment in the same round are Qiming Venture Partners, Sinopharm Capital, Sequoia Capital China. In the next rounds fund is usually obtained by Sequoia Capital China, OrbiMed, Lapam Capital.
Besides them, we counted 1 critical employee of this fund in our database.
Investments analytics
Analytics
- Total investments
- 47
- Lead investments
- 2
- Exits
- 4
- Rounds per year
- 4.27
- Follow on index
- 0.15
- Investments by industry
- Biotechnology (28)
- Health Care (25)
- Pharmaceutical (20)
- Medical (16)
- Biopharma (10) Show 15 more
- Investments by region
-
- China (38)
- United States (7)
- Peak activity year
- 2021
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 34M
- Group Appearance index
- 0.89
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Avenzo Therapeutics | 26 Mar 2024 | Early Stage Venture | 150M | United States, California, San Diego | |
| Yuesai Biotechnology | 14 Mar 2022 | Seed | 30M | Shandong, Pudong, China |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.